A Clinical Trial of ACYW135 Group Meningococcal Polysaccharide Conjugate Vaccine (CRM197 Vector) in a 4 to 6 Year-old Population

Clinical trial NCT06011200 · COMPLETED

Trial details

NCT number: NCT06011200
Sponsor: CanSino Biologics Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Epidemic Meningitis

Start date: 2023-09-16
Primary completion: 2023-12-11
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.